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Temporary axillobifemoral bypass as an adjunct to
endovascular aneurysm repair using fenestrated
stent grafts
Brian J. Manning, MD, FRCSI, Obiekezie Agu, MS, FRCS, Toby Richards, MD, FRCS,
Krassi Ivancev, MD, PhD, and Peter L. Harris, MD, FRCS, London, England
Prolonged endovascular procedures requiring a large diameter sheath in each groin can be associated with significant
intraoperative lower limb ischemia, particularly in those with pre-existing peripheral vascular disease. We report the case
of a patient who suffered severe ischemia-reperfusion injury following endovascular repair of a pararenal aortic aneurysm
using a fenestrated stent graft and describe the use of temporary axillobifemoral bypass in a patient with similar
comorbidities undergoing the same procedure. We propose this adjunctive technique as a means of maintaining antegrade
limb perfusion and avoiding the peripheral and central metabolic consequences of ischemia-reperfusion injury. (J Vasc
Surg 2011;53:867-9.)
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pEndovascular aneurysm repair (EVAR) requires the
presence of large diameter introducer sheaths in the com-
mon femoral arteries to facilitate stent graft delivery to the
aorta and iliac vessels. Fenestrated stent grafts require a
large sheath in each common femoral artery, simultane-
ously, increasing lower limb ischemia time and the risk of
significant reperfusion injury with cardiac, renal, and
pulmonary, as well as peripheral vascular consequences.
Patients with pre-existing peripheral arterial occlusive dis-
ease are known to be at increased risk of complications
following EVAR.1 In this report, we describe our experi-
ence of a patient who suffered complications of prolonged
lower limb ischemia during endovascular aneurysm repair.
We propose temporary axillobifemoral bypass as a strategy
to avoid potentially significant ischemia-reperfusion injury
in those patients anticipated as being at increased risk from
the presence of large diameter introducers in the femoral/
iliac vessels during complex aneurysm repair, and we de-
scribe its use in one such patient.
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Case one. A 78-year-old male underwent elective en-
ovascular repair on an 8.3 cm juxtarenal aortic aneurysm.
omorbidities included peripheral vascular disease and cor-
nary artery disease with previous coronary artery bypass
rafts, as well as chronic renal impairment with baseline
reatinine of 174 mol/L. Bilateral hypogastric artery oc-
lusions, severe calcification of external iliac and femoral
rteries, and left superficial femoral artery and popliteal
rtery occlusions, as well as stenotic lesion of the right
uperficial femoral artery and profunda femoris arteries
ere noted on preoperative imaging (ankle brachial pres-
ure indices, right 0.5/left 0.6). Calcification of the right
xternal iliac artery necessitated the use of a 10 mm
acron conduit for device delivery, and this was con-
erted to an iliofemoral bypass graft at the end of the
rocedure. A fenestrated stent graft was inserted with
overed stents for both renal arteries as well as the
uperior mesenteric artery. Completion angiography
onfirmed successful aneurysm exclusion. Owing to dif-
culty with access vessels as well as challenging anatomy
t the aneurysm neck, the procedure was prolonged (420
inutes). Size 20 Fr sheaths on both sides led to signif-
cant intraoperative lower limb ischemia. At the comple-
ion of the procedure, clinically apparent ischemia fol-
owing reperfusion necessitated fasciotomy, as well as
ight popliteal artery exploration and thombectomy (pH
t completion of surgery 7.13, base deficit 14.1mEq/L). The
ollowing day, a right femoral to posterior tibial bypass was
erformed, but the patient’s condition failed to improve.
ardiorespiratory and acute renal failure ensued, and ulti-
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March 2011868 Manning et almately ischemia of the contralateral lower limb and death
on the third postoperative day.
Case two. An 82-year-old male patient presented for
elective repair of a juxtarenal abdominal aortic aneurysm.
Comorbidities included coronary artery disease with previ-
ous coronary artery bypass grafts, as well as chronic obstruc-
tive airways disease, chronic renal insufficiency (baseline
creatinine, 143 mol/L), and peripheral vascular disease
(ankle brachial pressure indices, 0.4/0.5). A fenestrated
stent graft was planned to preserve flow to both renal
arteries and the superior mesenteric artery by means of
covered stents and a scallop allowing for the coeliac artery.
Prior to commencement of the endovascular procedure,
and anticipating the presence of a large (20 Fr) sheath in
each groin for a prolonged period, a temporary axillo-
bifemoral bypass was performed from the right axillary
artery to the bifurcation of the common femoral artery on
each side (Fig). The fenestrated stent graft delivery and
deployment was then performed, inserting the sheaths
proximal to the anastomoses of the axillobifemoral bypass.
The procedure was prolonged owing to difficulty catheter-
izing the right renal artery (procedure time, 525 minutes).
Completion angiography confirmed successful aneurysm
exclusion with preservation of flow to visceral and hypogas-
tric vessels. The temporary bypass was removed, leaving a
cuff of Dacron as a patch at each anastomosis. Despite the
prolonged procedure time there was no clinically significant
reperfusion injury or acidosis, with postoperative pH of
Fig. Temporary axillobifemoral bypass in situ prior to commence-
ment of the endovascular procedure. The graft is extracorporeal
from the right axillary artery to each groin, with the femoral
anastomoses allowing adequate space for 20 Fr introducers proxi-
mally, below the inguinal ligament.7.33 and Base Excess of 2.3 mEq/L. Postoperative recov- 2ry was uneventful with no cardiac renal or respiratory
omplications.
ISCUSSION
The physiological consequences of large introducers
n the femoral arteries during endovascular aneurysm
epair are probably underestimated. Johnnson et al2
eported that lower limb lactate and lactate:pyruvate
atio were significantly higher after EVAR than after
pen aneurysm repair and remained elevated for at least
8 hours while levels after open repair continued close to
aseline. They estimated 70% introducer-sheath-related
rterial occlusion in this series in patients without pe-
ipheral vascular disease. They point out that the dura-
ion of lower-limb ischemia in standard infra-renal
VAR is approximately twice that for open repair. While
he consequences of ischemia are seen rarely in associa-
ion with procedures of 3- to 4-hour durations or less,
or more complex endovascular reconstructions, such as
n the first patient described in this report, the conse-
uences may be profound: severe ischemia-reperfusion
njury causing metabolic acidosis and compartment syn-
rome progressing to multiple organ dysfunction and
eath. The pathophysiology has been defined; anaerobic
etabolism of ischemic muscle increases serum lactate and
ydrogen ion concentration, while potassium, phosphate,
nd creatine kinase leak out of cells. Lactate directly de-
resses myocardial contractility. Reperfusion is associated
ith complement activation and increase in proinflamma-
ory cytokines including tumor necrosis factor alpha, which
epresses both systolic and diastolic cardiac function. Ele-
ated potassium levels increase the risk of cardiac arrhyth-
ias, while upregulation of pro-thrombotic eicosanoids
urther increases the risk of coronary or small artery throm-
osis. Longer ischemia times increase the likelihood of
eutrophil-mediated lung injury in a spectrum of conse-
uences ranging from the systemic inflammatory response
yndrome to multiple organ dysfunction. Muscle ischemia
an cause rhabdomyolysis with deposition of myoglobin
nd creatine kinase causing acute tubular necrosis.3
Temporary axillobifemoral bypass by preventing isch-
mia minimizes the risk of reperfusion injury and the asso-
iated metabolic consequences. The second case illustrates
his in a similarly prolonged complex procedure undertaken
n the context of similar comorbidities. Clinically significant
eripheral vascular disease has been consistently reported as
n independent predictor of mortality after EVAR, ranking
econd only to dialysis dependency in a recent report.1
omplete sheath-induced arterial occlusion is more likely
n this scenario, and where the sheath extends across the
ypogastric origin, or in the setting of occlusive disease of
his vessel, the lower extremity and pelvic ischemia is com-
ounded further. In this report, both patients had signifi-
ant peripheral vascular disease and both underwent aneu-
ysm treatment using “triple fenestrated” stent grafts (ie,
hose with fenestrations for renal and superior mesenteric
rteries). For these cases, in addition to the ipsilateral 20 or
2 Fr introducer, a 20 or 24 Fr introducer is required to
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those patients requiring only two fenestrations, a smaller
contralateral sheath is sufficient (possibly allowing for some
flow to the contralateral leg around the sheath). Alterna-
tively, the contralateral artery can be punctured separately
for each 6 or 7 Fr sheath, but this is not practical when three
sheaths (and possibly a further introducer for an angio-
graphic catheter) are required.
While this is the first report to our knowledge of this
adjunctive procedure in the setting of endovascular aneu-
rysm repair, temporary axillofemoral bypass has been pre-
viously described as an adjunct to open aortic aneurysm
repair.4-7 It has been described primarily as a means of
left-ventricular afterload reduction in those with congestive
cardiac failure, rather than as a means of avoiding lower-
limb ischemia. Aortic cross clamping is associated with
increased afterload (mean aortic pressure) and results in a
hyperdynamic circulatory state, with increased heart rate
and proximal systolic pressure associated with increased
myocardial oxygen requirement and potential for subendo-
cardial ischemia. Temporary axillobifemoral bypass is a
routine adjunctive procedure for open repair of juxtarenal
aortic aneurysms in the setting of congestive cardiac failure,
in at least one large contemporary series.8 Although no data
exist on the cardiac hemodynamic effect of large introduc-
ers in the iliac arteries during endovascular procedures, the
principles are the same, and cardiac afterload reduction by
means of temporary extra-anatomical bypass merits consid-
eration in those at risk. Temporary axillobifemoral bypass
has the disadvantage or requiring an addition 60 to 90
minutes of operating time as well as the potential for
intraoperative bleeding at one or more of the three anasto-
moses in patients fully heparinized (activated clotting time
was monitored throughout both cases with a target of 300
seconds). Our practice of leaving a small cuff of prosthetic
material at each anastomosis at the time of graft excision
predisposes to infective complications during follow-up.
Since our first use of this technique in the patient described, Se have adopted the practice for all patients anticipated to
equire prolonged fenestrated procedures, particularly
hose with significant peripheral vascular disease, with pos-
tive experience in all eight patients managed in this way to
ate (of a consecutive series of 45 patients treated with
enestrated stent grafts).
ONCLUSION
Endovascular repair of pararenal aortic aneurysms with
enestrated stent grafts has the potential for significant
schemia-reperfusion injury, particularly in the setting of
eripheral vascular disease or hypogastric artery occlusion.
emporary intraoperative axillobifemoral bypass will pre-
ent this complication and should be considered in selected
atients.
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